Member Info for donotpanic

Could be BLUE in next 30 minutes... soon buying is going to be very hard...

Looking very much now we are going to move upwards and very quick... repeat of yesterday... but only change will be we will break 35... we hit 25 as low yesterday and 28 was sort of low today...

I will not be surprised GDR goes RED and ODX big BLUE... Ready for bounce now...

GDR TOP HIT AT 82... now dropping... hope no one got spiked there... ODX bottom hit at 29 and now watch t BOUNCE... Hope no one panic sold...

De-rampers missed yesterdays RISE... The are looking to get in cheap... PUMP will come here soon.

35-40 this could hit.. similar pattern as yesterday... up drop then BOOM

Always have buy-sell target.. I do have a feeling... tomorrow we could get may be little spike then shake then up... or little shake then up.. remember lot people bought in around 26 just before spike..

See how sentiments change .. 32 plus close.

NT to buy now... 32 close more likely if MMS let it go..

Full ask 30 to buy.

30 plus today hopefully

SYNOOGOLD I bought gdr 46 yesterday and sold at 70.. I did not want to be greedy

Will be impossible to buy before 29/30

Watch it move ….

Reached my target in GDR bought more here… spike coming

WE ALL saw how this moves... was it last week from 22-23 to 33 can happen again... never buy-sell reading boards ... read news.. I still feel this is well oversold and should be around 35... as 4 million in bank and food nutrition business growing

I STILL FEEL THIS WILL COME GOOD... If any one look at GDR board only month or so ... that board was exactly like this... ALL this needs is good RNS and watch price move and sentiment change...

Defo no one should be selling after this RNS but buying as this is low enough...

Mix messages but I still feel this will be bought.. sooner then we think... May be TB wants his mates in..

As previously indicated, the Paraytec team will commence a prospective clinical study early in the new year, followed by a longitudinal study. Discussions with potential commercial partners and acquirers are now continuing in some depth, with some prospective counter parties having completed a third round of such meetings. The Braveheart board continues to assess what is likely to result in the best outcome for shareholders, whether it is from the potential sale, partnership or retention and full development of the technology.



Omicron: The Paraytec and Sheffield University team are confident that the test will work with Omicron and other variants, as Paraytec's test to detect the COVID-19 virus uses antibodies to attach a specific fluorescent dye to the surface of each virus particle. The antibodies used in the test have been selected to recognise the viral Spike protein. While mutations in the Omicron variant give rise to over 30 amino acid changes in the Spike protein, all of these occur in a region of the protein which is distinct from that recognised by the antibodies selected for the Paraytec test.